RISK BASED INSPECTION [WHO TRS 986-POINT (39.17)]
![RISK BASED INSPECTION [WHO TRS 986-POINT (39.17)]](https://pharmadevils.com/wp-content/uploads/2024/11/WHO-TRS-986-39.17-768x1087.jpg)
In a risk-based inspection, WHO TRS 986 – Point 39.17 (as used in the risk-based inspection checklist) requires inspectors to verify the firm’s procedure for (1) selecting environmental monitoring (EM) sampling locations and (2) interpreting EM results for the sterile…





![RISK BASED INSPECTION [SCHEDULE M-POINT (34.14)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-39.14-768x1087.jpg)
![RISK BASED INSPECTION [WHO TRS 986-POINT (39.12)]](https://pharmadevils.com/wp-content/uploads/2024/11/WHO-TRS-986-39.12-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (39.8)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-39.8-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (39.6)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-39.6-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (39.5)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-39.5-2-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (39.4)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-39.4-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (39.3)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-39.3-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE L1-POINT (38.5)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-L1-38.5-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE L1-POINT (38.4)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-L1-38.4-768x1086.jpg)